Increasing focus on research and development activities in the pharmaceutical and biotechnology industries is expected to drive the growth of the preparative and process chromatography market. Additionally, the growing demand for biopharmaceuticals and the increasing investment in healthcare infrastructure are further fueling market growth. Technological advancements in chromatography techniques are also contributing to the expansion of the market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Type, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | GE Healthcare, Danaher Corp., Merck KGaA, Bio-Rad Laboratories, Thermo Fisher Scientific, Shimadzu Corp., Agilent Technologies, Waters, Novasep Holding S.A.S |
High cost associated with preparative and process chromatography equipment and consumables is a major restraint for market growth. Additionally, the lack of skilled professionals in the field of chromatography is posing a challenge for market players. These factors are hindering the adoption of preparative and process chromatography systems, especially in emerging economies.